Raymond C Glowaky
Inventor
Stats
- 5 US patents issued
- 18 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 5 US Patents Issued
- 18 US Applications Filed
- 201 Total Citation Count
- Sep 21, 2023 Most Recent Filing
- Dec 4, 1978 Earliest Filing
Work History
| Patent Owner | Applications Filed | Year |
|---|---|---|
| RHODES TECHNOLOGIES | 1
1 | 2014
2016 |
| PFIZER INC. | 1
1 1 | 1978
1987 1989 |
| CULTOR FOOD SCIENCE, INC. | 1
| 1994
|
| CULTOR OY | 1
| 1994
|
| MARINUS PHARMACEUTICALS, INC. | 2
| 2016
|
| OFPG | 1
| 1987
|
| TIORCO, INC. | 1
| 1987
|
| DANISCO CULTOR AMERICA, INC. (PREVIOUSLY CULTOR FOOD SCIENCE, INC.) | 1
| 1994
|
| S.N.F. | 1
| 1987
|
Inventor Addresses
| Address | Duration |
|---|---|
| Groton, CT | Feb 11, 97 - Feb 11, 97 |
| Killingworth, CT, US | Aug 11, 16 - Jan 18, 24 |
| New York, NY | Feb 19, 91 - Feb 19, 91 |
| Niantic, CT | Mar 03, 81 - Apr 10, 90 |
Technology Profile
| Technology | Matters | |
|---|---|---|
| A23L: | FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT | 1 |
| A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 12 |
| C07D: | HETEROCYCLIC COMPOUNDS | 6 |
Patents / Publication
| Patents / Publication # | Year of Publication / Issued | Title | Citations |
|---|---|---|---|
| 2024/0016,817 | 2024 | Intravenous Ganaxolone Formulations and Methods of Use in Treating Status Epilepticus and Other Seizure Disorders | 0 |
| 11773107 | 2023 | Opioid ketal compounds and uses thereof | 0 |
| 2023/0293,549 | 2023 | INTRAVENOUS GANAXOLONE FORMULATIONS AND METHODS OF USE IN TREATING STATUS EPILEPTICUS AND OTHER SEIZURE DISORDERS | 0 |
| 11731979 | 2023 | Opioid ketal compounds and uses thereof | 0 |
| 2023/0181,600 | 2023 | INJECTABLE NEUROSTEROID FORMULATIONS CONTAINING NANOPARTICLES | 0 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.